3 results Ā· Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmActive, not recruitingPhase 22026-10-01NCT02227251
ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System PacingArrhythmias, Cardiac, Bites and Stings, Bradycardia, Cardiac Conduction System Disease, Chemically-Induced Disorders, Fascicular Block, Left Bundle-Branch Block, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tachycardia, Ventricular Dysfunction, atrial fibrillation, atrioventricular block, atrioventricular dissociation, cardiovascular disorder, heart disorder, heart failure, injury, poisoning, progressive familial heart block, type 1A, systolic heart failure, third-degree atrioventricular block, ventricular fibrillation, ventricular tachycardiaRecruitingNot stated2024-03-22NCT06324682
Molecular Characterizazion and Biological Samples Centralisation of Patients Affected by Oncoematolofic PathologyHemic and Lymphatic Diseases, hematologic disorderRecruitingNot applicable2024-03-12NCT06304194